Results 191 to 200 of about 75,241 (308)

Flexibility and Dynamicity Enhances and Controls Supramolecular Self‐Assembly of Zinc(II) Metallogels

open access: yesAdvanced Functional Materials, EarlyView.
Zinc(II) coordination complexes with tunable aryloxy‐imine ligands exhibit controllable supramolecular self‐assembly into hierarchical fibrous structures. Coordination‐driven stacking, not π–π interactions, enables gelation, dynamic assembly/disassembly, and enhanced nanomechanical properties.
Merlin R. Stühler   +10 more
wiley   +1 more source

Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study. [PDF]

open access: yesBMC Med, 2022
Ardissino M   +8 more
europepmc   +1 more source

Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of single oral administration.

open access: bronze, 1990
Hisatoshi Oribe   +8 more
openalex   +2 more sources

Edge‐Delocalized Electron Effect on Self‐Expediating Desolvation Kinetics for Low‐Temperature Li─S Batteries

open access: yesAdvanced Functional Materials, EarlyView.
The self‐transformed Schottky heterojunction on MXene is developed to facilitate the dissociation of Li (solvent)x+ to achieve fast Li+ desolvation to promote rapid sulfur conversion kinetics by decreasing the related barriers, contributing to high‐performance Li─S batteries under low‐temperatures.
Yongzheng Zhang   +12 more
wiley   +1 more source

Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records. [PDF]

open access: yesNeuropsychopharmacology
Þorsteinsson H   +11 more
europepmc   +1 more source

Calcium Channel Blocker-Like Action of Reserpine in Smooth Muscle

open access: gold, 1992
Takumi SATOH   +3 more
openalex   +1 more source

Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer

open access: yesAdvanced Functional Materials, EarlyView.
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy